FUJIFILM Healthcare Americas Corporation, a provider of diagnostic imaging and medical informatics solutions, announced that it has been awarded a second, four-year contract for its surgical C-arm systems by the Defense Logistics Agency (DLA). Under the contract, Fujifilm will outfit multiple U.S. military medical treatment facilities for the U.S. Army, Air Force, Navy and Marines with the company’s Persona C mobile fluoroscopy system, a surgical C-arm designed for imaging across a broad range of diagnostic imaging and minimally invasive surgical procedures.
In December 2021, the company was awarded its first four-year from the U.S. Army and Defense Logistics Agency to deploy its surgical C-arm technology at multiple medical treatment facilities. The first C-arm system delivery and installation under the new contract is slated to begin in early Q1 of 2025, followed by additional installations throughout the next four years.
Fujifilm’s contract award valued more than $10 million was granted after a detailed evaluation of and comparison against numerous competitive C-arm technologies. Following a comprehensive assessment of each manufacturer’s system technology, functionality, adaptability, service support infrastructure and cybersecurity compliance, Fujifilm was selected as the singular vendor that best met or exceeded the U.S. Military’s exacting standards and demanding criteria.
Fujifilm has been awarded grants by various branches of the U.S. Federal Government. This latest contract follows Fujifilm's announcement that its ASPIRE Cristalle Acquisition Workflow System (AWS), the workstation that is used in conjunction with the company’s 3D mammography system, has been granted a Risk Management Framework (RMF) and Authority to Operate (ATO) on U.S. Department of Defense (DoD) networks. In November 2023, the DoD granted Fujifilm authority to operate Synapse® 7x – the company’s next-generation enterprise imaging platform – on U.S. Department of Defense (DoD) networks.
